Keyphrases
Anemia
45%
Anticoagulants
26%
Anticoagulation
53%
Antiphospholipid Syndrome
33%
Atrial Fibrillation
22%
Bleeding
26%
Blood Storage
22%
Bone Marrow
19%
Chronic Myeloid Leukemia
26%
Clinical Outcomes
17%
Clinical Significance
21%
Confidence Interval
40%
Deep Vein Thrombosis
22%
Direct Oral Anticoagulants
31%
Enoxaparin
20%
Essential Thrombocythemia
24%
Hazard Ratio
29%
Hematological Malignancies
20%
Hemophagocytic Lymphohistiocytosis
19%
High-grade Serous Ovarian Cancer (HGSOC)
23%
Integrin
73%
Israel
47%
Israeli
34%
Low Molecular Weight Heparin
30%
Major Bleeding
26%
Myelofibrosis
33%
Myeloma Cells
22%
Myeloproliferative Neoplasms
58%
Ovarian Cancer
40%
OVCAR-3
26%
Physician Survey
19%
Platelets
29%
Polycythemia Vera
29%
Pulmonary Embolism
20%
Recurrent Venous Thromboembolism
23%
Red Cells
21%
Risk Factors
17%
Splanchnic Vein Thrombosis
20%
Thrombophilia
24%
Thrombosis
44%
Thyroid Hormones
100%
Total Knee Replacement
26%
Tranexamic Acid
26%
Transfusion
22%
Tumor Growth
18%
Tyrosine Kinase Inhibitor
19%
Vena Cava Filters
23%
Venous Thromboembolism
57%
Venous Thrombosis
23%
Warfarin
21%
Medicine and Dentistry
Anemia
38%
Anticoagulation
60%
Antiphospholipid Antibody
16%
Antiphospholipid Syndrome
26%
Antithrombotic
36%
B-Cell Chronic Lymphocytic Leukemia
17%
Bleeding
33%
Blood Storage
15%
Cancer
18%
Cell Line
16%
Deep Vein Thrombosis
20%
Direct Oral Anticoagulant
17%
Disease
53%
Erythrocyte
22%
Hazard Ratio
25%
Hematologic Malignancy
20%
Hematoma
14%
Hemophagocytic Syndrome
19%
Infection
17%
Inferior Vena Cava Filter
25%
Integrin
55%
Internal Medicine
23%
Low Molecular Weight Heparin
22%
Major Bleeding
26%
Malignant Neoplasm
35%
Mitogen-Activated Protein Kinase
15%
Myelofibrosis
30%
Myeloproliferative Neoplasm
56%
Neoplasm
14%
Odds Ratio
15%
Ovarian Cancer
47%
Phlebothrombosis
40%
Platelet
27%
Polycythemia vera
21%
Prevalence
25%
Pulmonary Embolism
21%
Randomized Controlled Trial
15%
Recurrent Disease
21%
Retrospective Study
23%
Symptom
19%
Thrombocytosis
16%
Thromboembolism
21%
Thrombophilia
17%
Thrombosis
49%
Thyroid Hormone
65%
Thyroid Hormone Derivative
14%
Total Knee Arthroplasty
19%
Tranexamic Acid
19%
Venae cavae
26%
Venous Thromboembolism
64%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
19%
Anticoagulant Agent
34%
Atrial Fibrillation
21%
Bleeding
57%
Blood Clotting Factor 10a
13%
Cardiolipin Antibody
13%
Chronic Lymphatic Leukemia
19%
Chronic Myeloid Leukemia
19%
Clinical Study
16%
Cohort Study
14%
Danazol
13%
Deep Vein Thrombosis
14%
Desmopressin
13%
Dexamethasone
13%
Direct Oral Anticoagulant
28%
Disease
43%
Enoxaparin
13%
Hematologic Malignancy
18%
Hemophagocytic Syndrome
13%
Infection
16%
Integrin
47%
Low Molecular Weight Heparin
26%
Lung Embolism
11%
Malignant Neoplasm
49%
Momelotinib
13%
Multiple Myeloma
20%
Myelodysplastic Syndrome
11%
Myelofibrosis
26%
Myeloma
28%
Myeloproliferative Neoplasm
23%
Neoplasm
23%
Nonhodgkin Lymphoma
13%
Ovary Cancer
39%
Phosphatidylserine
13%
Polycythemia vera
16%
Protein Tyrosine Kinase Inhibitor
13%
Randomized Controlled Trial
15%
Ruxolitinib
15%
Symptom
15%
Thrombin
17%
Thromboembolism
27%
Thrombosis
23%
Thrombotic Thrombocytopenic Purpura
13%
Thyroid Hormone
80%
Thyroid Hormone Derivative
14%
Tranexamic Acid
26%
Tumor Growth
14%
Vein Thrombosis
15%
Venous Thromboembolism
61%
Warfarin
21%